Nxera Pharma Co (TSE:4565) Change In Inventory: 円-2,395 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4565 Nxera Pharma Co Ltd TSE:4565
74 GF Score
Price 円1,105.00
GF Value 円835.72
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Nxera Pharma Co Change In Inventory?

Nxera Pharma Co TSE:4565 +1.66% 74 Change In Inventory is 円-2,395 Mil as of Jun. 2026. GuruFocus rates TSE:4565 with a GF Score™ of 74/100 and a GF Value™ of 円835.72 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Nxera Pharma Co's change in inventory for the quarter that ended in Jun. 2026 was 円0 Mil. It means Nxera Pharma Co's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Nxera Pharma Co's change in inventory for the fiscal year that ended in Dec. 2025 was 円-2,456 Mil. It means Nxera Pharma Co's inventory increased by 円2,456 Mil from Dec. 2024 to Dec. 2025 .

Nxera Pharma Co's Total Inventories for the quarter that ended in Jun. 2026 was 円10,071 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Nxera Pharma Co's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nxera Pharma Co  (TSE:4565) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nxera Pharma Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=10616.5/0*365 / 4
=N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nxera Pharma Co's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0 / 10616.5
=0.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nxera Pharma Co's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=10616.5 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co Change In Inventory Related Terms

Nxera Pharma Co Change In Inventory Historical Data

* Premium members only.

The historical data trend for Nxera Pharma Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co Change In Inventory Chart

Nxera Pharma Co Annual Data
Trend Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -32.00 1,908.00 -5,935.00 -2,456.00

Nxera Pharma Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.00 -913.00 -1,663.00 132.00 0.00
TSE:4565
74GF Score
Nxera Pharma Co Ltd TSE:4565
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nxera Pharma Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-2,395 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of 円-2,395 Mil mean?
Nxera Pharma Co (TSE:4565) has a Change In Inventory of 円-2,395 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Nxera Pharma Co and its competitors.
Is Nxera Pharma Co's Change In Inventory too high?
Nxera Pharma Co's current Change In Inventory is 円-2,395 Mil. Overall, Nxera Pharma Co has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nxera Pharma Co's Change In Inventory compare to VRTX and REGN?
Nxera Pharma Co's Change In Inventory of 円-2,395 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Nxera Pharma Co and its competitors. Nxera Pharma Co's current Change In Inventory is 円-2,395 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nxera Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Nxera Pharma Co (TSE:4565) is currently considered Significantly Overvalued. The stock's GF Value™ is 円835.72, compared to a current price of 円1,105.00 — trading 32.2% above its estimated fair value. The current Change In Inventory is 円-2,395 Mil. Nxera Pharma Co's overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Nxera Pharma Co (TSE:4565), the current Change In Inventory is 円-2,395 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nxera Pharma Co (TSE:4565) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be overvalued. The current stock price of 円1,105.00 is trading 32.2% above its estimated GF Value™ of 円835.72. GuruFocus considers Nxera Pharma Co to be Significantly Overvalued.

Key valuation signals for TSE:4565:

  • Change In Inventory: 円-2,395 Mil
  • GF Value™: 円835.72 vs. price of 円1,105.00 (32.2% above fair value)
  • GF Score™: 74/100 with 9 warning signs

No single metric tells the full story. See the TSE:4565 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nxera Pharma Co Business Description

Other Exchanges SOLTF:USA
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
74GF Score

Get the complete analysis for TSE:4565

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,105.00
Price
円835.72
GF Value